For the first time in over 25 years (since the approval of oxybutynin in 1972), better medications are available for the overactive bladder. With the recent approval of tolterodine and oxybutynin ...

for the treatment of overactive bladder (OAB).This is the first time that CTAF has addressed this topic.

Antimuscarinic drugs are the first-line treatment for overactive bladder. However, traditional formulations are associated with a number of adverse effects, most notably dry mouth. A study ...

Sumitomo Pharma’s oral treatment for overactive bladder symptoms has won an expanded label from the FDA, and is now approved ...

Generally, there’s a certain number of times you should pee daily. Deviating too far from this can suggest various things ...

The US subsidiary of Japan’s Sumitomo Pharma announced that the US Food and Drug Administration (FDA) has approved Gemtesa ...

Urination problems affect millions of men worldwide, often developing so gradually that many dismiss early warning signs.

As a result, the bladder muscles are relaxed when filling up with urine, which allows the bladder to contain its urine instead of sending the brain signals of urinary urgency. When this happens, ...

best ipl betting app in india New oral TYK2 inhibitor! InnoCare Pharma's Class 1 new drug clinical trial application accepted FDA approves first new oral drug for overactive bladder The three giants ...

Discover how the frequency of your urination can reveal important insights about your health. Learn the causes of frequent ...

The tibial neuromodulation devices market is projected to grow significantly, with an estimated value of USD 97.7 million in ...